Foreign terrorist fighters (FTF) returning or relocating from conflict zones pose a serious threat for Jammu & Kashmir on the India-Pakista...

"There is a general tendency to extend the term to their families. Using the term FTFs for children may lead to stigmatisation and dehumani...

The brokerage believes the acquisition of the domestic business of Wockhardt Pharma is value accretive for the company.

EPFO at a recent meeting decided to cut the current investment of Rs 15,000 crore in AAA-rated bonds by Rs 3000 crore and invest that amoun...

Veterans say demonetisation will certainly hurt India’s growth to some extent in the near term, but it is positive for the nation’s long-te...

India has described the worldwide terror threat and blocking finance for terrorism as a “daunting” challenges and suggested effective mecha...

"Dr Reddy’s, with the kind of buyback that they have announced, is going to be EPS accretive"

Indian generic drug producers are devising fresh strategies to continue benefiting from the world’s largest pharmaceutical market the Unite...

Shares of Sun Pharma surged 2.68 per cent or Rs 15.35 to close at Rs 587.25 as the all-share deal’s swap ratio is seen to favour investors ...

Shares of Ranbaxy Laboratories continued to remain under selling pressure for second straight session after the US FDA banned it from shipp...

“Most of the tampering happened at the time of filing the Abbreviated New Drug Applications to US Food and Drug Administration,” said a sen...

The pharmaceutical major’s Q1 net profit fell 90 per cent to Rs 126 crore as against a net profit of Rs 1,246 crore YoY.

Drug maker Dr Reddy’s Laboratories launched Levofloxacin tablets, used to treat bacterial infections after getting an approval from the US ...

In India, the company’s planned efforts through project ‘Viraat’ have borne fruit leading to higher than industry growth for the company.

Angel Broking has recommended a sell rating for Ranbaxy Laboratories after a warning was issued against the company from US FDA for its Ohm...

Emkay Global Financial Services is of the view that the warning to Ranbaxy Laboratories’ Ohm plant will sentimentally dampen its stock pric...

Pharma major Dr Reddy’s Labs is planning to storm the US generics market by launching around 200 products over the next five years.